Literature DB >> 15062611

Pulmonary effects of illicit drug use.

Armand J Wolff1, Anne E O'Donnell.   

Abstract

The lungs are at considerable risk from the use of injected or inhaled illicit drugs. The extent and clinical significance of illicit drug induced lung damage is not known completely. Drug use leads to an increase in infectious pulmonary disease, historically in relation to nonsterile injection techniques, and, more recently, in relation to HIV infection and its pulmonary manifestations. Barotrauma related to "smoking topography" or errant injections also represents a real risk of drug use. Although granulomatous disease that involves the pulmonary vasculature and interstitium is probably common in injection drug users, the clinical consequence of such is difficult to estimate. What effect smoked or injected illicit drugs have on short- and long-term pulmonary function also is hard to ascertain. The ubiquitous use of tobacco among users of illicit drugs certainly has confounding effects. Given that illicit drug use is common and that the "popular" drugs of abuse change from generation to generation, the pulmonary physician must remain informed about, and alert for, the effects of drugs of abuse.

Entities:  

Mesh:

Year:  2004        PMID: 15062611     DOI: 10.1016/S0272-5231(03)00137-0

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  10 in total

1.  Emerging and Underrecognized Complications of Illicit Drug Use.

Authors:  Alysse G Wurcel; Elisabeth A Merchant; Roger P Clark; David R Stone
Journal:  Clin Infect Dis       Date:  2015-08-12       Impact factor: 9.079

Review 2.  Effects of marijuana smoking on pulmonary function and respiratory complications: a systematic review.

Authors:  Jeanette M Tetrault; Kristina Crothers; Brent A Moore; Reena Mehra; John Concato; David A Fiellin
Journal:  Arch Intern Med       Date:  2007-02-12

3.  Pulmonary Function in HIV-Infected Recreational Drug Users in the Era of Anti-Retroviral Therapy.

Authors:  Joseph A Simonetti; Matthew R Gingo; Lawrence Kingsley; Cathy Kessinger; Lorrie Lucht; Gk Balasubramani; Joseph K Leader; Laurence Huang; Ruth M Greenblatt; John Dermand; Eric C Kleerup; Alison Morris
Journal:  J AIDS Clin Res       Date:  2014-11

Review 4.  Stimulant abuse: pharmacology, cocaine, methamphetamine, treatment, attempts at pharmacotherapy.

Authors:  Daniel Ciccarone
Journal:  Prim Care       Date:  2011-01-11       Impact factor: 2.907

Review 5.  Stimulants and the lung : review of literature.

Authors:  Will Tseng; Mark E Sutter; Timothy E Albertson
Journal:  Clin Rev Allergy Immunol       Date:  2014-02       Impact factor: 8.667

6.  The validity of cocaine dependence subtypes.

Authors:  Henry R Kranzler; Marsha Wilcox; Roger D Weiss; Kathleen Brady; Victor Hesselbrock; Bruce Rounsaville; Lindsay Farrer; Joel Gelernter
Journal:  Addict Behav       Date:  2007-05-24       Impact factor: 3.913

7.  The Impact of Substance Use Disorder on COVID-19 Outcomes.

Authors:  Jacques Baillargeon; Efstathaia Polychronopoulou; Yong-Fang Kuo; Mukaila A Raji
Journal:  Psychiatr Serv       Date:  2020-11-03       Impact factor: 3.084

8.  Return to Galileo? The Inquisition of the International Narcotic Control Board.

Authors:  Dan Small; Ernest Drucker
Journal:  Harm Reduct J       Date:  2008-05-07

9.  Massive hemoptysis in intravenous drug users: case report and review of literature.

Authors:  V Aiyappan; M Muthiah
Journal:  Ann Thorac Med       Date:  2007-01       Impact factor: 2.219

10.  Septic pulmonary emboli causing recurrent bilateral pneumothoraces in a patient with right sided endocarditis: A case report and review of literature.

Authors:  Sumit Kapoor; Jyotsana Thakkar; Muhammad Asim Siddique
Journal:  SAGE Open Med Case Rep       Date:  2018-07-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.